PDB Short entry for 1OO8 HEADER HYDROLASE INHIBITOR 03-MAR-03 1OO8 TITLE CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1-ANTITRYPSIN PRECURSOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 26-418; COMPND 5 SYNONYM: ALPHA-1 PROTEASE INHIBITOR, ALPHA-1- ANTIPROTEINASE, COMPND 6 PRO0684/PRO2209; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: LIVER; SOURCE 6 TISSUE: HEPATOCYTES; SOURCE 7 CELL: NEUTROPHILS; SOURCE 8 CELLULAR_LOCATION: CYTOPLASM; SOURCE 9 GENE: SERPINA1 OR PI OR AAT; SOURCE 10 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 11 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 12 EXPRESSION_SYSTEM_STRAIN: SG13009; SOURCE 13 EXPRESSION_SYSTEM_CELL_LINE: SG13900; SOURCE 14 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 15 EXPRESSION_SYSTEM_PLASMID: PQE30; SOURCE 16 EXPRESSION_SYSTEM_GENE: ALPHA-1-ANTITRYPSIN KEYWDS SERPIN, PITTSBURGH VARIANT, HYDROLASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR A.DEMENTIEV,M.SIMONOVIC,K.VOLZ,P.G.GETTINS REVDAT 7 16-AUG-23 1OO8 1 REMARK REVDAT 6 27-OCT-21 1OO8 1 SEQADV REVDAT 5 04-APR-18 1OO8 1 REMARK REVDAT 4 24-FEB-09 1OO8 1 VERSN REVDAT 3 13-JAN-04 1OO8 1 JRNL REVDAT 2 30-SEP-03 1OO8 1 JRNL REVDAT 1 05-AUG-03 1OO8 0 JRNL AUTH A.DEMENTIEV,M.SIMONOVIC,K.VOLZ,P.G.GETTINS JRNL TITL CANONICAL INHIBITOR-LIKE INTERACTIONS EXPLAIN REACTIVITY OF JRNL TITL 2 ALPHA1-PROTEINASE INHIBITOR PITTSBURGH AND ANTITHROMBIN WITH JRNL TITL 3 PROTEINASES JRNL REF J.BIOL.CHEM. V. 278 37881 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12860985 JRNL DOI 10.1074/JBC.M305195200 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.6 REMARK 3 NUMBER OF REFLECTIONS : 12381 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1256 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1702 REMARK 3 BIN R VALUE (WORKING SET) : 0.2670 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 157 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2881 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 123 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.10000 REMARK 3 B22 (A**2) : 10.77000 REMARK 3 B33 (A**2) : -8.67000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.34 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.840 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.530 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.700 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.190 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.470 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.26 REMARK 3 BSOL : 35.91 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.PARAM REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OO8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAR-03. REMARK 100 THE DEPOSITION ID IS D_1000018495. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-01 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 6.30 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER + MIRRORS REMARK 200 OPTICS : FOCUSING MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12840 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 4.880 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.12 REMARK 200 R MERGE FOR SHELL (I) : 0.56400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1QLP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M TRI-POTASSIUM CITRATE, 20% PEG REMARK 280 -3350, PH 6.30, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.68000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 104.25000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.50500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 104.25000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.68000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 26.50500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 PRO A 3 REMARK 465 GLN A 4 REMARK 465 GLY A 5 REMARK 465 ASP A 6 REMARK 465 ALA A 7 REMARK 465 ALA A 8 REMARK 465 GLN A 9 REMARK 465 LYS A 10 REMARK 465 THR A 11 REMARK 465 ASP A 12 REMARK 465 THR A 13 REMARK 465 SER A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 ASP A 17 REMARK 465 GLN A 18 REMARK 465 ASP A 19 REMARK 465 HIS A 20 REMARK 465 PRO A 21 REMARK 465 THR A 22 REMARK 465 PHE A 23 REMARK 465 LYS A 394 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 25 CG CD CE NZ REMARK 470 LYS A 125 CG CD CE NZ REMARK 470 LYS A 135 CG CD CE NZ REMARK 470 LYS A 155 CG CD CE NZ REMARK 470 LYS A 163 CG CD CE NZ REMARK 470 GLN A 166 CG CD OE1 NE2 REMARK 470 ASP A 171 CG OD1 OD2 REMARK 470 ASP A 177 CG OD1 OD2 REMARK 470 ARG A 178 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 257 CG CD OE1 OE2 REMARK 470 THR A 345 OG1 CG2 REMARK 470 GLU A 346 CG CD OE1 OE2 REMARK 470 GLN A 393 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS A 343 CA LYS A 343 C -0.362 REMARK 500 ARG A 358 N ARG A 358 CA 0.213 REMARK 500 ARG A 358 C SER A 359 N 0.195 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 343 N - CA - C ANGL. DEV. = 23.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 25 -23.75 -150.75 REMARK 500 LEU A 84 -9.68 -56.13 REMARK 500 HIS A 139 37.64 35.90 REMARK 500 THR A 150 -76.05 -49.89 REMARK 500 GLU A 151 9.60 -55.35 REMARK 500 GLN A 166 28.57 48.50 REMARK 500 ASP A 171 52.27 36.13 REMARK 500 ASP A 177 -174.66 -67.03 REMARK 500 ASP A 179 38.69 -86.10 REMARK 500 ALA A 284 145.07 -177.68 REMARK 500 VAL A 321 -73.39 -88.97 REMARK 500 THR A 345 172.47 124.38 REMARK 500 ALA A 348 -156.56 -111.94 REMARK 500 ALA A 350 -82.92 -33.70 REMARK 500 MET A 351 84.80 84.47 REMARK 500 PHE A 352 170.92 -59.59 REMARK 500 SER A 359 162.37 -43.53 REMARK 500 REMARK 500 REMARK: NULL DBREF 1OO8 A 1 394 UNP P01009 A1AT_HUMAN 26 418 SEQADV 1OO8 MET A 1 UNP P01009 INITIATING METHIONINE SEQADV 1OO8 LEU A 51 UNP P01009 PHE 75 ENGINEERED MUTATION SEQADV 1OO8 ALA A 59 UNP P01009 THR 83 ENGINEERED MUTATION SEQADV 1OO8 ALA A 68 UNP P01009 THR 92 ENGINEERED MUTATION SEQADV 1OO8 GLY A 70 UNP P01009 ALA 94 ENGINEERED MUTATION SEQADV 1OO8 SER A 232 UNP P01009 CYS 256 ENGINEERED MUTATION SEQADV 1OO8 ARG A 358 UNP P01009 MET 382 ENGINEERED MUTATION SEQADV 1OO8 ILE A 374 UNP P01009 MET 398 ENGINEERED MUTATION SEQADV 1OO8 ALA A 381 UNP P01009 SER 405 ENGINEERED MUTATION SEQADV 1OO8 ARG A 387 UNP P01009 LYS 411 ENGINEERED MUTATION SEQRES 1 A 394 MET ASP PRO GLN GLY ASP ALA ALA GLN LYS THR ASP THR SEQRES 2 A 394 SER HIS HIS ASP GLN ASP HIS PRO THR PHE ASN LYS ILE SEQRES 3 A 394 THR PRO ASN LEU ALA GLU PHE ALA PHE SER LEU TYR ARG SEQRES 4 A 394 GLN LEU ALA HIS GLN SER ASN SER THR ASN ILE LEU PHE SEQRES 5 A 394 SER PRO VAL SER ILE ALA ALA ALA PHE ALA MET LEU SER SEQRES 6 A 394 LEU GLY ALA LYS GLY ASP THR HIS ASP GLU ILE LEU GLU SEQRES 7 A 394 GLY LEU ASN PHE ASN LEU THR GLU ILE PRO GLU ALA GLN SEQRES 8 A 394 ILE HIS GLU GLY PHE GLN GLU LEU LEU ARG THR LEU ASN SEQRES 9 A 394 GLN PRO ASP SER GLN LEU GLN LEU THR THR GLY ASN GLY SEQRES 10 A 394 LEU PHE LEU SER GLU GLY LEU LYS LEU VAL ASP LYS PHE SEQRES 11 A 394 LEU GLU ASP VAL LYS LYS LEU TYR HIS SER GLU ALA PHE SEQRES 12 A 394 THR VAL ASN PHE GLY ASP THR GLU GLU ALA LYS LYS GLN SEQRES 13 A 394 ILE ASN ASP TYR VAL GLU LYS GLY THR GLN GLY LYS ILE SEQRES 14 A 394 VAL ASP LEU VAL LYS GLU LEU ASP ARG ASP THR VAL PHE SEQRES 15 A 394 ALA LEU VAL ASN TYR ILE PHE PHE LYS GLY LYS TRP GLU SEQRES 16 A 394 ARG PRO PHE GLU VAL LYS ASP THR GLU GLU GLU ASP PHE SEQRES 17 A 394 HIS VAL ASP GLN VAL THR THR VAL LYS VAL PRO MET MET SEQRES 18 A 394 LYS ARG LEU GLY MET PHE ASN ILE GLN HIS SER LYS LYS SEQRES 19 A 394 LEU SER SER TRP VAL LEU LEU MET LYS TYR LEU GLY ASN SEQRES 20 A 394 ALA THR ALA ILE PHE PHE LEU PRO ASP GLU GLY LYS LEU SEQRES 21 A 394 GLN HIS LEU GLU ASN GLU LEU THR HIS ASP ILE ILE THR SEQRES 22 A 394 LYS PHE LEU GLU ASN GLU ASP ARG ARG SER ALA SER LEU SEQRES 23 A 394 HIS LEU PRO LYS LEU SER ILE THR GLY THR TYR ASP LEU SEQRES 24 A 394 LYS SER VAL LEU GLY GLN LEU GLY ILE THR LYS VAL PHE SEQRES 25 A 394 SER ASN GLY ALA ASP LEU SER GLY VAL THR GLU GLU ALA SEQRES 26 A 394 PRO LEU LYS LEU SER LYS ALA VAL HIS LYS ALA VAL LEU SEQRES 27 A 394 THR ILE ASP GLU LYS GLY THR GLU ALA ALA GLY ALA MET SEQRES 28 A 394 PHE LEU GLU ALA ILE PRO ARG SER ILE PRO PRO GLU VAL SEQRES 29 A 394 LYS PHE ASN LYS PRO PHE VAL PHE LEU ILE ILE GLU GLN SEQRES 30 A 394 ASN THR LYS ALA PRO LEU PHE MET GLY ARG VAL VAL ASN SEQRES 31 A 394 PRO THR GLN LYS FORMUL 2 HOH *123(H2 O) HELIX 1 1 ILE A 26 GLN A 44 1 19 HELIX 2 2 SER A 53 SER A 65 1 13 HELIX 3 3 LEU A 66 ALA A 68 5 3 HELIX 4 4 LYS A 69 LEU A 80 1 12 HELIX 5 5 PRO A 88 ASN A 104 1 17 HELIX 6 6 VAL A 127 LEU A 137 1 11 HELIX 7 7 ASP A 149 LYS A 163 1 15 HELIX 8 8 GLU A 199 THR A 203 5 5 HELIX 9 9 LYS A 259 LEU A 267 1 9 HELIX 10 10 THR A 268 ASN A 278 1 11 HELIX 11 11 LEU A 299 GLN A 305 1 7 HELIX 12 12 THR A 309 SER A 313 5 5 SHEET 1 A 7 ILE A 50 PHE A 52 0 SHEET 2 A 7 PRO A 382 VAL A 388 -1 O ARG A 387 N ILE A 50 SHEET 3 A 7 PHE A 370 GLU A 376 -1 N PHE A 372 O GLY A 386 SHEET 4 A 7 ALA A 248 PRO A 255 -1 N PHE A 253 O VAL A 371 SHEET 5 A 7 SER A 237 TYR A 244 -1 N MET A 242 O ALA A 250 SHEET 6 A 7 THR A 214 SER A 232 -1 N SER A 232 O SER A 237 SHEET 7 A 7 GLU A 204 ASP A 211 -1 N PHE A 208 O VAL A 216 SHEET 1 B 8 ILE A 50 PHE A 52 0 SHEET 2 B 8 PRO A 382 VAL A 388 -1 O ARG A 387 N ILE A 50 SHEET 3 B 8 PHE A 370 GLU A 376 -1 N PHE A 372 O GLY A 386 SHEET 4 B 8 ALA A 248 PRO A 255 -1 N PHE A 253 O VAL A 371 SHEET 5 B 8 SER A 237 TYR A 244 -1 N MET A 242 O ALA A 250 SHEET 6 B 8 THR A 214 SER A 232 -1 N SER A 232 O SER A 237 SHEET 7 B 8 ARG A 282 PRO A 289 -1 O ARG A 282 N PHE A 227 SHEET 8 B 8 GLU A 363 LYS A 365 1 O VAL A 364 N HIS A 287 SHEET 1 C 5 GLU A 141 VAL A 145 0 SHEET 2 C 5 THR A 113 SER A 121 1 N LEU A 118 O PHE A 143 SHEET 3 C 5 PHE A 182 LYS A 191 -1 O VAL A 185 N GLY A 117 SHEET 4 C 5 LYS A 331 ILE A 340 1 O VAL A 333 N ASN A 186 SHEET 5 C 5 LEU A 291 ASP A 298 -1 N LEU A 291 O ILE A 340 CRYST1 39.360 53.010 208.500 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025407 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018864 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004796 0.00000